Bi Asset Management Fondsmaeglerselskab A Vertex Pharmaceuticals Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

$5.3 Billion
Q1 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 68,508 shares of VRTX stock, worth $32.1 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

68,508

Previous 58,100 17.91%

Holding current value

$32.1 Million

Previous $23.6 Million 21.14%

% of portfolio

0.54%

Previous 0.5%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$407.69 - $446.08 $4.24 Million - $4.64 Million	10,408 Added 17.91%	68,508 $28.6 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $1.31 Million - $1.56 Million	-3,810 Reduced 6.15%	58,100 $23.6 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $3.61 Million - $3.87 Million	10,673 Added 20.83%	61,910 $21.5 Million
Q2 2023 Aug 03, 2023	SELL	$314.42 - $351.91 $1.58 Million - $1.77 Million	-5,041 Reduced 8.96%	51,237 $18 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $1.76 Million - $2.01 Million	6,231 Added 12.45%	56,278 $17.7 Million

Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $1.06 Million - $1.19 Million	3,705 Added 7.99%	50,047 $14.5 Million
Q3 2022 Nov 07, 2022	SELL	$273.83 - $305.53 $2.03 Million - $2.26 Million	-7,408 Reduced 13.78%	46,342 $13.4 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $3.59 Million - $4.47 Million	-15,296 Reduced 22.15%	53,750 $15.1 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $2.18 Million - $2.57 Million	-9,831 Reduced 12.46%	69,046 $18 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $78,415 - $98,988	-443 Reduced 0.56%	78,877 $17.3 Million
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $4.28 Million - $4.79 Million	23,573 Added 42.29%	79,320 $14.4 Million
Q2 2021 Aug 06, 2021	SELL	$187.49 - $221.1 $1.01 Million - $1.19 Million	-5,371 Reduced 8.79%	55,747 $11.2 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $1.42 Million - $1.65 Million	6,851 Added 12.62%	61,118 $13.1 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $6.31 Million - $8.42 Million	30,501 Added 128.34%	54,267 $12.8 Million
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $1.47 Million - $1.74 Million	5,757 Added 31.97%	23,766 $6.47 Million
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $2.73 Million - $3.59 Million	12,128 Added 206.22%	18,009 $5.23 Million
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $817,458 - $1.01 Million	4,092 Added 228.73%	5,881 $1.4 Million
Q4 2019 Mar 19, 2020	SELL	$166.71 - $223.91 $59,515 - $79,935	-357 Reduced 16.64%	1,789 $392,000
Q3 2019 Mar 19, 2020	BUY	$166.23 - $187.09 $25,433 - $28,624	153 Added 7.68%	2,146 $364,000
Q2 2019 Mar 19, 2020	BUY	$164.61 - $190.37 $328,067 - $379,407	1,993 New	1,993 $365,000

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Vertex Pharmaceuticals Inc Transaction History